CareDx, Inc
Index- P/E- EPS (ttm)-0.94 Insider Own1.40% Shs Outstand53.02M Perf Week-1.45%
Market Cap1.34B Forward P/E410.48 EPS next Y0.06 Insider Trans-12.29% Shs Float52.15M Perf Month-16.47%
Income-49.60M PEG- EPS next Q-0.05 Inst Own- Short Float8.49% Perf Quarter-32.18%
Sales308.40M P/S4.34 EPS this Y-45.80% Inst Trans3.77% Short Ratio5.40 Perf Half Y-41.40%
Book/sh8.63 P/B3.00 EPS next Y115.00% ROA-8.90% Target Price60.29 Perf Year-65.40%
Cash/sh6.17 P/C4.19 EPS next 5Y20.00% ROE-10.60% 52W Range21.25 - 96.88 Perf YTD-43.14%
Dividend- P/FCF- EPS past 5Y24.50% ROI-6.10% 52W High-76.49% Beta0.89
Dividend %- Quick Ratio5.90 Sales past 5Y48.80% Gross Margin66.70% 52W Low7.20% ATR2.52
Employees633 Current Ratio6.10 Sales Q/Q17.80% Oper. Margin-15.50% RSI (14)37.80 Volatility8.53% 9.41%
OptionableYes Debt/Eq0.00 EPS Q/Q- Profit Margin-16.10% Rel Volume2.29 Prev Close25.86
ShortableYes LT Debt/Eq0.00 EarningsMay 05 AMC Payout- Avg Volume818.89K Price22.78
Recom1.60 SMA20-17.52% SMA50-30.44% SMA200-52.60% Volume482,231 Change-11.91%
Apr-25-22Initiated Stephens Overweight $50
Jul-20-21Resumed BTIG Research Buy $115
Jun-03-21Initiated Goldman Buy $95
Feb-26-21Downgrade H.C. Wainwright Buy → Neutral
Oct-30-20Reiterated H.C. Wainwright Buy $47 → $55
Oct-08-20Reiterated H.C. Wainwright Buy $45 → $47
Oct-02-20Reiterated H.C. Wainwright Buy $40 → $45
Aug-05-20Reiterated H.C. Wainwright Buy $37 → $40
Jun-26-20Initiated BTIG Research Buy $40
Jun-19-20Reiterated H.C. Wainwright Buy $40 → $37
Oct-01-19Resumed Craig Hallum Buy $48
May-09-19Upgrade H.C. Wainwright Neutral → Buy $30 → $43
Feb-15-19Initiated Jefferies Buy $35
Oct-23-18Resumed Raymond James Strong Buy $30
Sep-18-18Reiterated H.C. Wainwright Neutral $17 → $22
Nov-27-17Initiated H.C. Wainwright Buy $12
Jun-14-16Reiterated Mizuho Buy $12 → $8
Sep-29-15Downgrade Raymond James Outperform → Mkt Perform
Sep-25-15Initiated Craig Hallum Buy
Mar-18-15Reiterated Mizuho Buy $15 → $12
May-18-22 07:00AM  
May-17-22 07:00AM  
May-16-22 09:00AM  
May-11-22 07:00AM  
May-05-22 05:35PM  
Apr-29-22 07:05AM  
Apr-28-22 10:45AM  
Apr-27-22 04:01PM  
Apr-22-22 07:00AM  
Apr-21-22 07:10AM  
Apr-20-22 07:00AM  
Apr-14-22 07:41AM  
Apr-11-22 07:00AM  
Apr-06-22 07:00AM  
Mar-30-22 07:00AM  
Mar-29-22 07:00AM  
Mar-24-22 07:00AM  
Mar-23-22 07:00AM  
Mar-16-22 04:01PM  
Mar-15-22 11:20AM  
Mar-14-22 08:06PM  
Mar-03-22 07:00AM  
Mar-02-22 07:00AM  
Feb-24-22 05:50PM  
Feb-22-22 07:00AM  
Feb-17-22 04:01PM  
Feb-14-22 07:00AM  
Feb-10-22 07:00AM  
Feb-08-22 07:00AM  
Feb-07-22 07:00AM  
Feb-03-22 07:00AM  
Feb-02-22 05:38PM  
Jan-27-22 01:38PM  
Jan-25-22 10:53AM  
Jan-20-22 07:00AM  
Jan-19-22 05:38PM  
Jan-14-22 09:38AM  
Jan-12-22 07:00AM  
Jan-11-22 07:00AM  
Jan-10-22 07:00AM  
Jan-07-22 07:00AM  
Jan-06-22 07:00AM  
Jan-05-22 07:00AM  
Jan-04-22 07:00AM  
Dec-31-21 07:45PM  
Dec-30-21 05:51PM  
Dec-29-21 05:51PM  
Dec-27-21 06:01PM  
Dec-26-21 08:27AM  
Dec-24-21 06:34PM  
Dec-22-21 06:14PM  
Dec-21-21 06:12PM  
Dec-20-21 06:02PM  
Dec-19-21 04:36PM  
Dec-18-21 02:38AM  
Dec-17-21 06:34PM  
Dec-16-21 06:49PM  
Dec-13-21 07:00AM  
Dec-12-21 09:00PM  
Dec-10-21 12:30PM  
Dec-07-21 09:00PM  
Dec-03-21 08:06PM  
Dec-02-21 09:00PM  
Dec-01-21 06:32PM  
Nov-30-21 06:23PM  
Nov-29-21 06:02PM  
Nov-28-21 08:22AM  
Nov-27-21 05:00AM  
Nov-26-21 06:24PM  
Nov-25-21 06:18PM  
Nov-24-21 07:33PM  
Nov-23-21 08:07PM  
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company also offers TruSight HLA, a next generation sequencing (NGS) based high resolution typing solution; Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; and XynQAPI transplant quality tracking and waitlist management solutions, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Colon GraceDirectorMay 11Sale23.015,179119,1692,522May 13 05:21 PM
Goldberg MichaelDirectorApr 11Option Exercise1.2250061062,767Apr 13 05:12 PM
Goldberg MichaelDirectorApr 11Sale36.0150018,00662,267Apr 13 05:12 PM
Maag PeterDirectorApr 05Option Exercise21.749,950216,277321,689Apr 06 05:03 PM
Maag PeterDirectorApr 05Sale38.6410,000386,394311,689Apr 06 05:03 PM
Seeto ReginaldSee RemarksMar 21Sale40.432,888116,774187,282Mar 23 05:05 PM
Goldberg MichaelDirectorMar 09Option Exercise1.2250061061,767Mar 11 05:16 PM
Goldberg MichaelDirectorMar 09Sale33.4150016,70461,267Mar 11 05:16 PM
Colon GraceDirectorMar 09Sale34.561,39348,1467,701Mar 11 05:15 PM
Maag PeterDirectorMar 07Option Exercise19.334,05678,382321,739Mar 08 05:16 PM
Maag PeterDirectorMar 07Sale32.8110,000328,063311,739Mar 08 05:16 PM
Seeto ReginaldSee RemarksMar 01Sale38.623,153121,754190,170Mar 01 08:49 PM
Bickerstaff GeorgeDirectorFeb 28Sale39.1125,000977,67337,736Mar 01 08:48 PM
Goldberg MichaelDirectorFeb 09Option Exercise1.2250061061,767Feb 10 05:23 PM
Seeto ReginaldSee RemarksFeb 09Sale45.002,550114,759190,170Feb 10 05:26 PM
Goldberg MichaelDirectorFeb 09Sale42.9650021,48061,267Feb 10 05:23 PM
Maag PeterDirectorFeb 07Sale42.0710,000420,668317,683Feb 08 09:58 PM
Seeto ReginaldSee RemarksFeb 04Sale40.344,988201,237192,720Feb 04 05:47 PM
Seeto ReginaldSee RemarksFeb 02Sale41.253,182131,258126,746Feb 04 05:47 PM
Seeto ReginaldSee RemarksFeb 01Sale42.1381434,294129,928Feb 03 08:26 PM
Seeto ReginaldSee RemarksJan 19Sale40.053,137125,634132,560Jan 19 04:49 PM
Seeto ReginaldSee RemarksJan 18Sale40.071,71968,881135,697Jan 19 04:49 PM
Goldberg MichaelDirectorJan 10Option Exercise1.2250061061,767Jan 11 05:52 PM
Goldberg MichaelDirectorJan 10Sale42.9750021,48561,267Jan 11 05:52 PM
Maag PeterDirectorJan 05Option Exercise24.3010,000242,986351,756Jan 06 06:07 PM
Maag PeterDirectorJan 05Sale44.4510,000444,466341,756Jan 06 06:07 PM
Goldberg MichaelDirectorDec 09Option Exercise1.2250061061,068Dec 13 06:30 PM
Goldberg MichaelDirectorDec 09Sale45.4150022,70560,568Dec 13 06:30 PM
Maag PeterDirectorDec 06Option Exercise18.9010,000188,951351,756Dec 07 04:29 PM
Maag PeterDirectorDec 06Sale41.6210,000416,190341,756Dec 07 04:29 PM
Dhingra AnkurChief Financial OfficerNov 24Buy42.345,000211,6945,000Nov 29 04:19 PM
Goldberg MichaelDirectorNov 09Option Exercise1.2250061061,068Nov 10 04:47 PM
Goldberg MichaelDirectorNov 09Sale47.5450023,77060,568Nov 10 04:47 PM
Maag PeterDirectorNov 05Option Exercise18.9010,000188,969351,756Nov 09 06:01 PM
TORRES ARTHUR ADirectorNov 05Buy47.6260028,5722,855Nov 09 05:47 PM
Maag PeterDirectorNov 05Sale49.4010,000494,000341,756Nov 09 06:01 PM
Goldberg MichaelDirectorOct 11Option Exercise1.2250061061,068Oct 12 05:19 PM
Goldberg MichaelDirectorOct 11Sale62.5050031,25160,568Oct 12 05:19 PM
Maag PeterExecutive ChairOct 05Option Exercise18.1710,000181,661351,756Oct 06 07:40 PM
Maag PeterExecutive ChairOct 05Sale64.6710,000646,735341,756Oct 06 07:40 PM
Maag PeterExecutive ChairSep 07Option Exercise10.653,44836,718351,756Sep 07 08:36 PM
Maag PeterExecutive ChairSep 07Sale73.6810,000736,763341,756Sep 07 08:36 PM
Seeto ReginaldSee RemarksAug 27Sale80.0065852,642142,534Aug 27 04:43 PM
Seeto ReginaldSee RemarksAug 11Option Exercise27.7210,821299,958143,192Aug 17 06:59 PM
Maag PeterExecutive ChairAug 05Option Exercise11.364,95856,333354,256Aug 09 04:56 PM
Maag PeterExecutive ChairAug 05Sale83.1310,000831,313349,298Aug 09 04:56 PM
Seeto ReginaldSee RemarksJul 08Sale85.675,994513,503132,634Jul 09 07:28 PM
Maag PeterExecutive ChairJul 06Option Exercise12.242,31228,299374,256Jul 07 06:31 PM
Maag PeterExecutive ChairJul 06Sale90.7010,000907,002364,256Jul 07 06:31 PM
Seeto ReginaldSee RemarksJun 28Option Exercise26.8413,212354,613145,583Aug 17 06:59 PM
Seeto ReginaldSee RemarksJun 28Sale95.7513,2121,264,990132,371Aug 17 06:59 PM
Maag PeterExecutive ChairJun 25Option Exercise24.353959,618372,339Jun 25 07:54 PM
Seeto ReginaldSee RemarksJun 25Option Exercise26.539,210244,359141,581Aug 17 06:59 PM
Seeto ReginaldSee RemarksJun 25Sale95.159,210876,318132,371Aug 17 06:59 PM
Maag PeterExecutive ChairJun 25Sale95.0039537,525371,944Jun 25 07:54 PM
Maag PeterExecutive ChairJun 24Option Exercise23.769,605228,217381,549Jun 25 07:54 PM
Maag PeterExecutive ChairJun 24Sale95.309,605915,398371,944Jun 25 07:54 PM
Maag PeterExecutive ChairJun 09Option Exercise24.352,52261,411374,466Jun 11 05:52 PM
HAGSTROM WILLIAM ADirectorJun 09Option Exercise4.955,00024,75023,575Jun 11 05:52 PM
King SashaChief Marketing OfficerJun 09Option Exercise5.255,05526,52052,574Jun 11 05:51 PM
Seeto ReginaldSee RemarksJun 09Option Exercise26.5616,718444,066159,352Jun 11 05:51 PM
King SashaChief Marketing OfficerJun 09Sale90.0112,4351,119,26340,139Jun 11 05:51 PM
HAGSTROM WILLIAM ADirectorJun 09Sale88.145,000440,70618,575Jun 11 05:52 PM
Maag PeterExecutive ChairJun 09Sale90.002,522226,982371,944Jun 11 05:52 PM
Seeto ReginaldSee RemarksJun 09Sale90.0116,7181,504,819142,634Jun 11 05:51 PM
Maag PeterExecutive ChairJun 08Option Exercise24.3597823,814372,922Jun 09 08:27 PM
King SashaChief Marketing OfficerJun 08Option Exercise16.041,00016,03748,519Jun 09 08:30 PM
Seeto ReginaldSee RemarksJun 08Option Exercise27.7250013,860143,134Jun 09 08:32 PM
King SashaChief Marketing OfficerJun 08Sale90.021,00090,02447,519Jun 09 08:30 PM
Maag PeterExecutive ChairJun 08Sale90.0597888,074371,944Jun 09 08:27 PM
Seeto ReginaldSee RemarksJun 08Sale90.0050045,001142,634Jun 09 08:32 PM
King SashaChief Marketing OfficerJun 07Option Exercise20.138,071162,43855,590Jun 08 06:37 PM
Seeto ReginaldSee RemarksJun 07Option Exercise27.729,973276,452152,607Jun 08 06:39 PM
Maag PeterExecutive ChairJun 07Option Exercise19.377,592147,021398,444Jun 08 06:41 PM
Maag PeterExecutive ChairJun 07Sale86.2526,5002,285,752371,944Jun 08 06:41 PM
Seeto ReginaldSee RemarksJun 07Sale90.019,973897,644142,634Jun 08 06:39 PM
King SashaChief Marketing OfficerJun 07Sale90.018,071726,46147,519Jun 08 06:37 PM
SNYDERMAN RALPHDirectorJun 02Sale81.572,511204,81551,015Jun 10 05:32 PM
SNYDERMAN RALPHDirectorJun 01Sale77.302,512194,17353,526Jun 10 05:32 PM
SNYDERMAN RALPHDirectorMay 28Sale81.082,511203,59556,038Jun 10 05:32 PM
SNYDERMAN RALPHDirectorMay 27Sale81.011,966159,26658,549Jun 10 05:32 PM
Maag PeterExecutive ChairMay 25Option Exercise27.1710,000271,700419,444May 27 05:04 PM
Maag PeterExecutive ChairMay 25Sale80.5910,000805,871409,444May 27 05:04 PM